drugset / Trial / NCT03346902
Study of EB-001 in Facial Scar Reduction
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will evaluate the safety and efficacy of EB-001 in improving wound healing and reducing scar formation in patients undergoing Mohs surgery for skin lesions in the forehead area following a single treatment of EB-001 when injected into the muscles underlying the incision area.
Timeline
- Start
- 2018-02-06
- Primary completion
- 2018-07-31
- Completion
- 2018-10-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | EB-001 | Protein / enzyme biologic | — | Intramuscular |
Indications
No indication recorded.